FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087891672> ?p ?o ?g. }

• W3087891672 endingPage "204062072095853" @default.
• W3087891672 startingPage "204062072095853" @default.
• W3087891672 abstract "Primary lymphoma of bone (PLB) is an extremely rare malignancy arising in the skeletal system. There is no consensus over the best definition of PLB. Most of the published articles are single-institutional retrospective studies with a limited sample size. The rarity of PLB and discrepancies on diagnostic criteria has resulted in a vague understanding of PLB.We retrospectively analyzed the clinical characteristics and prognostic factors of 2558 PLB patients who were registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2016. Survival rates were calculated using the Kaplan-Meier method. The effects of various factors on survival outcomes were analyzed by using the log-rank test. Univariate and multivariate analyses were conducted by using the Cox proportional hazards model to determine independent prognostic factors.The median follow-up time of all eligible patients was 58 months. There seemed no sex preponderance in PLB incidence. The most involved sites are axial skeletons. The most common histological subtype was diffuse large B-cell lymphoma. The 3-, 5-, 10-, and 20-year overall survival (OS) rates were 70.70%, 65.70%, 54.40% and 39.50%, respectively. PLB patients whose primary tumor sites were appendicular and craniofacial skeletons had a significant survival advantage [hazard ratio (HR) = 0.694, 95% confidence interval (CI) 0.552-0.872; HR = 0.729, 95% CI 0.597-0.889, respectively] over those with axial skeletons as primary tumor sites. Patients with Hodgkin lymphoma, non-Hodgkin lymphoma (NHL)-mature B-cell lymphoma, and NHL-precursor-cell lymphoblastic lymphoma also had a significant OS advantage (HR = 0.392, 95% CI 0.200-0.771; HR = 0.826, 95% CI 0.700-0.973; and HR = 0.453, 95% CI 0.223-0.923, respectively). Patients with Ann Arbor stage III-IV at diagnosis were at higher risk of death than those with stage I-II (HR = 1.348, 95% CI 1.107-1.641). Chemotherapy was an independent favorable prognostic factor (HR = 0.734, 95% CI 0.605-0.890).Primary anatomic site, histology type, higher Ann Arbor stage and chemotherapy were independent prognostic factors. Chemotherapy played a pivotal role in PLB treatment." @default.
• W3087891672 created "2020-10-01" @default.
• W3087891672 creator A5009055934 @default.
• W3087891672 creator A5023394486 @default.
• W3087891672 creator A5051746234 @default.
• W3087891672 creator A5056351079 @default.
• W3087891672 creator A5067708732 @default.
• W3087891672 creator A5067997175 @default.
• W3087891672 creator A5072638932 @default.
• W3087891672 date "2020-01-01" @default.
• W3087891672 modified "2023-10-12" @default.
• W3087891672 title "Primary lymphoma of bone: a population-based study of 2558 patients" @default.
• W3087891672 cites W1968179560 @default.
• W3087891672 cites W1969414253 @default.
• W3087891672 cites W1988199805 @default.
• W3087891672 cites W1993571744 @default.
• W3087891672 cites W2012562543 @default.
• W3087891672 cites W2014504782 @default.
• W3087891672 cites W2016150684 @default.
• W3087891672 cites W2026705518 @default.
• W3087891672 cites W2035964312 @default.
• W3087891672 cites W2051212011 @default.
• W3087891672 cites W2054558922 @default.
• W3087891672 cites W2061759565 @default.
• W3087891672 cites W2070095096 @default.
• W3087891672 cites W2073596862 @default.
• W3087891672 cites W2074326527 @default.
• W3087891672 cites W2090128635 @default.
• W3087891672 cites W2103787267 @default.
• W3087891672 cites W2105446438 @default.
• W3087891672 cites W2109217797 @default.
• W3087891672 cites W2120104264 @default.
• W3087891672 cites W2143580993 @default.
• W3087891672 cites W2151505576 @default.
• W3087891672 cites W2160248310 @default.
• W3087891672 cites W2167080445 @default.
• W3087891672 cites W2167941205 @default.
• W3087891672 cites W2471267718 @default.
• W3087891672 cites W2516912959 @default.
• W3087891672 cites W4293374619 @default.
• W3087891672 doi "https://doi.org/10.1177/2040620720958538" @default.
• W3087891672 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7502855" @default.
• W3087891672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32994912" @default.
• W3087891672 hasPublicationYear "2020" @default.
• W3087891672 type Work @default.
• W3087891672 sameAs 3087891672 @default.
• W3087891672 citedByCount "10" @default.
• W3087891672 countsByYear W30878916722021 @default.
• W3087891672 countsByYear W30878916722022 @default.
• W3087891672 countsByYear W30878916722023 @default.
• W3087891672 crossrefType "journal-article" @default.
• W3087891672 hasAuthorship W3087891672A5009055934 @default.
• W3087891672 hasAuthorship W3087891672A5023394486 @default.
• W3087891672 hasAuthorship W3087891672A5051746234 @default.
• W3087891672 hasAuthorship W3087891672A5056351079 @default.
• W3087891672 hasAuthorship W3087891672A5067708732 @default.
• W3087891672 hasAuthorship W3087891672A5067997175 @default.
• W3087891672 hasAuthorship W3087891672A5072638932 @default.
• W3087891672 hasBestOaLocation W30878916721 @default.
• W3087891672 hasConcept C107130276 @default.
• W3087891672 hasConcept C120665830 @default.
• W3087891672 hasConcept C121332964 @default.
• W3087891672 hasConcept C126322002 @default.
• W3087891672 hasConcept C143998085 @default.
• W3087891672 hasConcept C144301174 @default.
• W3087891672 hasConcept C167135981 @default.
• W3087891672 hasConcept C207103383 @default.
• W3087891672 hasConcept C2778476033 @default.
• W3087891672 hasConcept C2778476748 @default.
• W3087891672 hasConcept C2778559949 @default.
• W3087891672 hasConcept C2779338263 @default.
• W3087891672 hasConcept C2779399171 @default.
• W3087891672 hasConcept C2908647359 @default.
• W3087891672 hasConcept C38180746 @default.
• W3087891672 hasConcept C44249647 @default.
• W3087891672 hasConcept C50382708 @default.
• W3087891672 hasConcept C61511704 @default.
• W3087891672 hasConcept C71924100 @default.
• W3087891672 hasConcept C99454951 @default.
• W3087891672 hasConceptScore W3087891672C107130276 @default.
• W3087891672 hasConceptScore W3087891672C120665830 @default.
• W3087891672 hasConceptScore W3087891672C121332964 @default.
• W3087891672 hasConceptScore W3087891672C126322002 @default.
• W3087891672 hasConceptScore W3087891672C143998085 @default.
• W3087891672 hasConceptScore W3087891672C144301174 @default.
• W3087891672 hasConceptScore W3087891672C167135981 @default.
• W3087891672 hasConceptScore W3087891672C207103383 @default.
• W3087891672 hasConceptScore W3087891672C2778476033 @default.
• W3087891672 hasConceptScore W3087891672C2778476748 @default.
• W3087891672 hasConceptScore W3087891672C2778559949 @default.
• W3087891672 hasConceptScore W3087891672C2779338263 @default.
• W3087891672 hasConceptScore W3087891672C2779399171 @default.
• W3087891672 hasConceptScore W3087891672C2908647359 @default.
• W3087891672 hasConceptScore W3087891672C38180746 @default.
• W3087891672 hasConceptScore W3087891672C44249647 @default.
• W3087891672 hasConceptScore W3087891672C50382708 @default.
• W3087891672 hasConceptScore W3087891672C61511704 @default.
• W3087891672 hasConceptScore W3087891672C71924100 @default.

• next